BIOS artwork

BIOS

107 episodes - English - Latest episode: 3 months ago -

BIOS Podcast brings together cutting-edge insights from Life Science industry leaders at the forefront of innovation.


Join us in hearing from Founders, Investors, Professors, & Pharma operating at the intersection of Technology & Biology.


By Alix Ventures: Driving Patient Impact - Supporting early stage Life Science startups engineering biology to drive radical advances in human health.


Learn more @ BIOS.community / Alix.vc


__________________________________


Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.

Entrepreneurship Business Science Life Sciences
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

63. Immunotherapy Protein Engineering & Entrepreneurship w/ Dane Wittrup - Professor @ MIT

February 05, 2024 03:44 - 50 minutes - 51.5 MB

Professor Dane Wittrup attended the University of New Mexico as an undergraduate, graduating Summa Cum Laude with a Bachelors in Chemical Engineering in June, 1984. Wittrup went on to attend the California Institute of Technology in Pasadena, where he worked with Prof. James Bailey on flow cytometry and segregated modeling of recombinant populations of Saccharomyces cerevisiae. After obtaining his Ph.D. in Chemical Engineering with a minor in Biology in 1988, he spent a brief time working at...

62. Future of Scientific Journalism w/ Holden Thorp - Editor-in-Chief @ Science Journals

January 27, 2024 02:01 - 50 minutes - 47 MB

Holden Thorp became Editor-in-Chief of the Science family of journals on 28 October 2019. He came to Science from Washington University, where he was provost from 2013 to 2019 and professor from 2013 to 2023.  He is currently a professor at George Washington University and on leave to serve as the Editor-in-Chief at Science. Thorp joined Washington University after spending three decades at the University of North Carolina at Chapel Hill (UNC), where he served as the 10th chancellor from 20...

61. Frontier of Immunological Engineering w/ Darrell Irvine - Professor @ MIT

January 22, 2024 03:33 - 50 minutes - 45.3 MB

Darrell Irvine obtained an Honors Bachelor’s degree in engineering physics from the University of Pittsburgh. As a National Science Foundation graduate fellow, he then studied Polymer Science at MIT. Following completion of his PhD, he was a Damon Runyon-Walter Winchell postdoctoral fellow in immunology at the Beckman Center for Molecular and Genetic Medicine. He is presently a professor at the Massachusetts Institute of Technology and an investigator of the Howard Hughes Medical Institute. ...

60. Diagnostic Entrepreneurship w/ Stan Lapidus - Serial Entrepreneur / Former Founder & CEO @ Exact Sciences

June 26, 2023 01:22 - 50 minutes - 49.5 MB

Stan Lapidus is an inventor and entrepreneur who currently serves on a number of healthcare and medical technology boards.  He’s been founding CEO of three medical diagnostics companies. Two of them have been among the most successful diagnostics startups of all time: Cytyc Corp., which he founded in 1987 and which revolutionized early detection of cervical cancer through its development of the modern Pap test—the ThinPrep. The two ThinPrep prototypes are at the Smithsonian’s American Museu...

59. Future of ADCs w/ David Epstein - CEO @ Seagen

June 12, 2023 02:07 - 43 minutes - 54.2 MB

David Epstein joined Seagen as Chief Executive Officer and a member of the Board of Directors in 2022, bringing more than 30 years of drug development, deal making, commercialization and people leadership experience on a global scale. Prior to Seagen, he was executive partner at Flagship Pioneering. From 2010 to mid-2016 he served as Chief Executive Officer of Novartis Pharmaceuticals, a division of Novartis AG. Previously, David started and led Novartis’ Oncology and Molecular Diagnostic u...

58. Frontier of Immunology w/ Vijay Kuchroo - Professor @ Harvard

April 17, 2023 15:44 - 43 minutes - 53.8 MB

Vijay Kuchroo is the Samuel L. Wasserstrom Professor of Neurology at Harvard Medical School, Senior Scientist at Brigham and Women’s Hospital, and Co-Director of the Center for Infection and Immunity, at the Brigham Research Institutes, Boston. He is also an associate member of the Broad Institute, and a participant in a Klarman Cell Observatory project that focuses on T cell differentiation. He is the founding Director of the Evergrande Center for Immunologic Diseases at Harvard Medical Sch...

57. Future of Microfluidics w/ David Weitz - Professor @ Harvard / Core Faculty @ Wyss Institute

April 17, 2023 15:33 - 43 minutes - 45.3 MB

David Weitz is the Mallinckrodt Professor of Physics & Applied Physics and professor of Systems Biology at Harvard University. Weitz is best known for his work in the areas of diffusing-wave spectroscopy, microrheology, microfluidics, rheology, fluid mechanics, interface and colloid science, colloid chemistry, biophysics, complex fluids, soft condensed matter physics, phase transitions, the study of glass and amorphous solids, liquid crystals, self-assembly, surface-enhanced light scatterin...

56. Future of Gene Editing w/ David Liu - Professor @ Harvard / Vice Chairman @ Broad Institute

April 10, 2023 01:48 - 43 minutes - 45.9 MB

David Liu is the Richard Merkin Professor and director of the Merkin Institute of Transformative Technologies in Healthcare, vice-chair of the faculty at the Broad Institute of MIT and Harvard, the Thomas Dudley Cabot Professor of the Natural Sciences at Harvard University, and a Howard Hughes Medical Institute (HHMI) investigator. Liu’s research integrates chemistry and evolution to illuminate biology and enable next-generation therapeutics. His major research interests include the engineer...

55. Future of Nanotechnology w/ Chad Mirkin - Professor @ Northwestern

April 10, 2023 01:36 - 43 minutes - 55.5 MB

Chad Mirkin is the Director of the International Institute for Nanotechnology and the George B. Rathmann Prof. of Chemistry, Prof. of Chemical and Biological Engineering, Prof. of Biomedical Engineering, Prof. of Materials Science & Engineering, and Prof. of Medicine at Northwestern University. He is a chemist and a world-renowned nanoscience expert, who is known for his discovery and development of spherical nucleic acids (SNAs) and SNA-based biodetection and therapeutic schemes, the inve...

54. Foundations of Biotech w/ Harvey Lodish - Professor @ MIT / Founding Member @ Whitehead Institute

April 10, 2023 01:24 - 43 minutes - 44.5 MB

Harvey Lodish is a Founding Member of the Whitehead Institute for Biomedical Research. He is a Professor of Biology and a Professor of Biological Engineering at the Massachusetts Institute of Technology (MIT). He serves as a Member of the National Academy of Sciences and is an Associate (Foreign) Member of the European Molecular Biology Organization. He is also a Fellow of the American Association for the Advancement of Science, a Fellow of the American Academy of Arts and Sciences, and a Fe...

53. Future of Immunology w/ Jeff Bluestone - Professor Emeritus @ UCSF / Co-Founder & CEO @ Sonoma Biotherapeutics

January 30, 2023 02:05 - 43 minutes - 55.2 MB

Jeff Bluestone is the President and Chief Executive Officer of Sonoma Biotherapeutics and the A.W. and Mary Margaret Clausen Distinguished Professor Emeritus at the Diabetes Center of The University of California, San Francisco. Bluestone is a highly accomplished scientific researcher and international leader in the field of immunotherapy and has published more than 500 papers over nearly four decades focused on understanding the basic processes that control T-cell activation and immune tol...

52. AI & Patient Centricity in Pharma w/ Frank Nestle - Global Head of Research & CSO @ Sanofi

January 30, 2023 01:59 - 43 minutes - 57.1 MB

Frank Nestle is global head of research and chief scientific officer at Sanofi, with responsibility for its main therapeutic research areas of immunology and inflammation, oncology, neurology, rare diseases, hematology, and genomic medicine. Before joining Sanofi in 2016, Nestle was a professor and chair of cutaneous medicine and immunotherapy at King’s College London and practiced medicine at Guy’s and St. Thomas’ Hospital. At King’s College, he led research, translational clinical trials, ...

51. Future of SynBio w/ Jay Keasling - Professor @ Berkeley

November 16, 2022 04:59 - 43 minutes - 46.8 MB

Jay Keasling is the Philomathia Professor of Alternative Energy at the University of California, Berkeley in the Departments of Bioengineering and Chemical and Biomolecular Engineering, senior faculty scientist at Lawrence Berkeley National Laboratory, and Chief Executive Officer of the Joint BioEnergy Institute (JBEI). Dr. Keasling’s research focuses on the metabolic engineering of microorganisms for degradation of environmental contaminants or for environmentally friendly synthesis of drug...

50. Pioneering Bioorthogonal Chemistry w/ Carolyn Bertozzi - Professor @ Stanford & 2022 Nobel Laureate

October 15, 2022 19:27 - 43 minutes - 44.7 MB

Carolyn Bertozzi is the Anne T. and Robert M. Bass Professor of Chemistry and Professor of Chemical & Systems Biology (by courtesy) at Stanford University, the Baker Family Director at Sarafan ChEM-H, and an Investigator of the Howard Hughes Medical Institute. She completed her undergraduate degree in Chemistry from Harvard University in 1988 and her Ph.D. in Chemistry from UC Berkeley in 1993. After completing postdoctoral work at UCSF in the field of cellular immunology, she joined the UC ...

49. Engineering Precision Medicine w/ Joel Dudley - Partner @ Innovation Endeavors / Former CSO @ Tempus

October 15, 2022 19:19 - 43 minutes - 48.2 MB

Joel Dudley is a Partner @ Innovation Endeavors and an experienced leader, medical professional, researcher, and entrepreneur.  Joel previously served as the Chief Scientific Officer at Tempus, a company focused on bringing the power of data and artificial intelligence to healthcare. Before joining Tempus, Joel was an Associate Professor of Genetics and Genomic Sciences and founding Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. He a...

48. Future of Precision Health w/ Carlos Bustamante - Professor @ Stanford / Co-Founder & CEO @ Galatea

October 15, 2022 19:08 - 43 minutes - 52.3 MB

Carlos Bustamante, over the past 15 years, has led a multidisciplinary team working on problems at the interface of computational and biological sciences. Much of his research has focused on genomics technology and its application in medicine, agriculture, and evolutionary biology. His first academic appointment was at Cornell University's College of Agriculture and Life Sciences. There, much of his work focused on population genetics and agricultural genomics motivated by a desire to improv...

47. Taking Agency of Your Care (& Your Company) w/ Lee Cooper - Senior Director of Venture Investments @ Leaps by Bayer

June 21, 2022 19:36 - 43 minutes - 67.6 MB

Lee Cooper is Senior Director of Venture Investments @ Leaps by Bayer, where he aims to contribute to new biotechnologies that enable patients and communities to live healthier lives. Lee is on the faculty of Dartmouth’s Thayer School of Engineering and teaches “The Ecosystem for Bio-Innovation.” Prior to joining Leaps, Lee was Entrepreneur-in-Residence with RA Capital and founder of Enlight Bio, a biotech focused on genetic disease. Previously, Lee worked in corporate development for Modern...

46. Building Innovation Institutes w/ Patrick Hsu - Co-Founder @ Arc Institute / Assistant Professor @ UC Berkeley

June 21, 2022 16:46 - 43 minutes - 59.7 MB

Patrick Hsu is an Assistant Professor of Bioengineering at the University of California, Berkeley, and is a co-founder and core investigator at the Arc Institute. He is a pioneer of CRISPR technology. In his Lab at Berkeley, Patrick seeks to improve our understanding and ability to control genetic circuits for the advancement of human health. His academic work has been featured in multiple prestigious awards, including Forbes’ 30 Under 30, the NIH Early Independence Award, and the MIT Techno...

45. Translational Medicine & Public Health w/ David Kaufman - Partner @ Third Rock Ventures

June 21, 2022 15:59 - 43 minutes - 41.5 MB

David Kaufman is a Partner @ Third Rock Ventures. Before joining TRV, he was Chief Medical Officer and head of translational development at the Bill and Melinda Gates Medical Research Institute (MRI). He helped establish the Gates MRI as a "nonprofit biotech," developing novel drugs and vaccines for tuberculosis, malaria, enteric diseases, neonatal health, and other global health challenges. Prior to that, Kaufman led translational oncology at Merck Research Laboratories, where he oversaw i...

44. Design Thinking in Biotech w/ Chris Garabedian - CEO @ Xontogeny / Former CEO @ Sarepta

June 20, 2022 22:45 - 43 minutes - 52.6 MB

Chris Garabedian is the Chairman & CEO of Xontogeny where he supports companies with cutting-edge technologies from early development through clinical proof of concept. Chris has decades of leadership experience in the biopharmaceutical industry. From 2011 to 2015, Chris led the turnaround of Sarepta Therapeutics as CEO. Prior to that, Chris served as VP of Corporate Strategy at Celgene and has held multiple executive roles at Gilead across corporate development, marketing, and medical affai...

43. Future of Genetic Medicine w/ Scribe Therapeutics Founders - Ben Oakes & Dave Savage

April 11, 2022 02:23 - 43 minutes - 56.2 MB

Ben Oakes is Co-founder, President, & CEO @ Scribe Therapeutics. He has contributed to over 25 publications and patent applications across synthetic biology, molecular engineering, CRISPR, and zinc finger-based genetic modification. A previous Innovative Genomics Institute Entrepreneurial Fellow, Ben has been named to the San Francisco Business Times 40 Under 40, Endpoints 20 Under 40 in biopharma, Business Insider 30 Under 40 transforming healthcare, and the Biocom Life Sciences Catalyst Aw...

42. Pharma BD to TechBio VC w/ Becky Pferdehirt - Partner @ Andreessen Horowitz (a16z Bio + Health Fund) & Seth Lieblich - Principal @ 8VC (Bio Team)

March 16, 2022 09:08 - 43 minutes - 71.1 MB

Becky Pferdehirt is a Partner on the a16z bio investing team. She focuses on early stage companies building technology platforms for therapeutic discovery and development. Prior to joining Andreessen Horowitz, Becky worked at Amgen where she most recently led business development efforts for therapeutic platform partnerships. Before moving to BD Becky was a research scientist in Amgen R&D, focused on cell and gene therapy technology innovation. Becky completed her postdoctoral education at G...

41. Cell Free Systems w/ Michael Jewett - Professor @ Northwestern / Director @ NU Center for Synthetic Biology

March 07, 2022 17:31 - 43 minutes - 62.6 MB

Michael Jewett is the Charles Deering McCormick Professor of Teaching Excellence, a Professor of Chemical & Biological Engineering, & Co-Director of the Center for Synthetic Biology @ Northwestern University. He is also an Institute Fellow at the Northwestern Argonne Institute for Science & Engineering. Jewett’s lab seeks to re-conceptualize the way we engineer complex biological systems for compelling applications in medicine, materials, and energy by transforming biochemical engineering wi...

40. TechBio Era w/ Vik Bajaj - Managing Director @ Foresite Capital

March 04, 2022 05:42 - 43 minutes - 82.3 MB

Vik Bajaj is a Managing Director @ Foresite, evaluating and pursuing investments at the intersection of technology and life sciences, including in personalized and precision healthcare. Prior to joining Foresite Capital, Vik was the chief scientific officer of GRAIL, a life sciences company working to detect cancer early when it can be cured, and remains on its Scientific Advisory Board. He is also the co-founder and former chief scientific officer of Verily (formerly Google Life Sciences) ...

39. Future of Drug Delivery w/ Samir Mitragotri - Professor @ Harvard / Core Faculty @ Wyss Institute

February 23, 2022 01:10 - 43 minutes - 68.6 MB

Samir Mitragotri is the Hiller Professor of Bioengineering and Hansjörg Wyss Professor of Biologically Inspired Engineering. Samir is an elected member of the National Academies of Engineering and Medicine, and elected fellow of the American Institute of Medical and Biological Engineering, the American Association for the Advancement of Science, the National Academy of Inventors, the Controlled Release Society, the Biomedical Engineering Society, and the American Association of Pharmaceutica...

38. Future of Organoids w/ Hans Clevers - Organoid Pioneer & Professor @ Hubrecht Institute

February 20, 2022 22:58 - 43 minutes - 85.9 MB

Hans Clevers is Director & Professor of Molecular Genetics @ the Hubrecht Institute in the Netherlands. He is also University Professor at the University Utrecht and Oncode Investigator. Clevers is one of the world’s leading researchers on stem cells and their potential for regenerative therapy. Over the past decade, his lab has produced vital studies on stem cells and the nature of self-renewal pathways controlling stem cells. Clevers was the first researcher to demonstrate the existence of...

37. Biophysics & Rejuvenation w/ Stephen Quake - Professor @ Stanford / Co-President @ Chan Zuckerberg Biohub

February 20, 2022 21:20 - 43 minutes - 47.8 MB

Stephen Quake is the Lee Otterson Professor of Bioengineering & Professor of Applied Physics @ Stanford University & Co-President of the Chan Zuckerberg Biohub. Quake has invented many measurement tools for biology, including new DNA sequencing technologies that have enabled rapid analysis of the human genome and microfluidic automation that allows scientists to efficiently isolate individual cells and decipher their genetic code. Quake is also well known for inventing new diagnostic tools...

36. Building Biotech Ecosystems w/ John Flavin - Founder & CEO @ Portal Innovations

February 06, 2022 07:59 - 43 minutes - 76.7 MB

John Flavin is Founder & CEO @ Portal Innovations, a premier venture development engine that builds and invests in early stage life sciences ventures. Portal’s differentiated mix of crafted capital drives companies from scientific ideation to business creation, helping entrepreneurs translate cutting-edge technology into sustainable, global businesses with breakthrough products to help patients. Prior to launching Portal, John founded and built several life sciences companies including Pyxi...

35. Accelerating Diagnostic Innovation w/ David Walt - Professor @ Harvard / Core Faculty @ Wyss Institute

February 04, 2022 07:34 - 43 minutes - 69.6 MB

David Walt is the Hansjörg Wyss Professor of Bioinspired Engineering @ Harvard Medical School, Professor of Pathology @ Harvard Medical School & Brigham and Women’s Hospital, Core Faculty Member of the Wyss Institute @ Harvard University, Associate Member @ the Broad Institute, Howard Hughes Medical Institute Professor, & is co-Director of the Mass General Brigham Center for COVID Innovation. Walt pioneered the use of microwell arrays for single-molecule detection and genetic measurements, w...

34. Biologically Inspired Engineering w/ Don Ingber - Founding Director @ Wyss Institute / Professor @ Harvard

January 28, 2022 17:42 - 43 minutes - 73.9 MB

Don Ingber is the Founding Director of the Wyss Institute for Biologically Inspired Engineering @ Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He received his B.A., M.A., M.Phil., M.D. and Ph.D. from Yale University. Ingber is a pioneer in the field of biologically inspired ...

33. Immunoengineering w/ Dave Mooney - Professor @ Harvard / Core Faculty @ Wyss Institute

January 15, 2022 17:25 - 43 minutes - 70.4 MB

Dave Mooney is a leader in the fields of biomaterials, mechanotransduction, drug delivery, tissue engineering and immunoengineering. He is interested in understanding how cells sense signals in their environment and how this alters cell behavior. His laboratory develops biomaterials that exploit these signals to regulate specific cells and their function. They were the first to demonstrate in 3-D culture that the mechanical properties of a substrate regulated stem cell fate. His lab also dev...

32. Our Path to Mental Health w/ Tom Insel - Former Director @ NIMH / Co-Founder @ Mindstrong

December 27, 2021 23:10 - 43 minutes - 80.3 MB

Tom lnsel, psychiatrist & neuroscientist, has been a national leader in mental health research, policy, and technology. From 2002-2015, Insel served as Director of the National Institute of Mental Health (NIMH). More recently (2015 – 2017), he led the Mental Health Team at Verily (formerly Google Life Sciences) in South San Francisco, CA. In 2017 he co-founded Mindstrong Health, a Silicon Valley start-up building tools for people with serious mental illness. In 2019, Insel served as a specia...

31. The Future is AI w/ David Berry - Founder & CEO @ Valo Health / General Partner @ Flagship Pioneering

November 15, 2021 05:52 - 43 minutes - 30.5 MB

David Berry is Founder & CEO @ Valo. Since 2005, he has served as General Partner @ Flagship Pioneering, having founded over 25 companies including Indigo Agriculture, Seres Therapeutics (NASDAQ: MCRB), Eleven Biotherapeutics (NASDAQ: EBIO), T2 Biosystems (NASDAQ: TTOO), Evelo Biosciences (NASDAQ: EVLO), Axcella Health (NASDAQ: AXLA), and Joule Unlimited. David played an instrumental role in the conception and implementation of Flagship Labs, which is the foundation of all of its companies. ...

30. Protein Design & Innovation w/ David Baker - Professor @ UW

November 01, 2021 16:32 - 43 minutes - 25.1 MB

David Baker is the director of the Institute for Protein Design, a Howard Hughes Medical Institute Investigator, the Henrietta and Aubrey Davis Endowed Professor in Biochemistry, and an adjunct professor of genome sciences, bioengineering, chemical engineering, computer science, and physics at the University of Washington. His research group is focused on the design of macromolecular structures and functions. He received his Ph.D. in biochemistry with Randy Schekman at the University of Cal...

29. Translating SynBio w/ Jim Collins - Professor @ MIT / Core Faculty @ Wyss Institute

October 28, 2021 17:31 - 43 minutes - 28.4 MB

Jim Collins is The Termeer Professor of Bioengineering in the Department of Biological Engineering and Institute for Medical Engineering & Science @ MIT. He is also affiliated with the Broad Institute and the Wyss Institute. His research group works in synthetic biology and systems biology, with a particular focus on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. Professor Collins' patented technologies have been li...

29. Translating SynBio w/ Jim Collins - Professor @ MIT

October 28, 2021 17:31 - 43 minutes - 28.4 MB

Jim Collins is The Termeer Professor of Bioengineering in the Department of Biological Engineering and Institute for Medical Engineering & Science @ MIT. He is also affiliated with the Broad Institute and the Wyss Institute. His research group works in synthetic biology and systems biology, with a particular focus on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. Professor Collins' patented technologies have been li...

28. The World of OMICs w/ Mike Snyder - Professor @ Stanford

October 18, 2021 00:57 - 43 minutes - 32.1 MB

Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and currently carries out a variety of projects in the areas of genomics and proteomics both in yeast and humans. These include the large-scale analysis of proteins using protein mi...

27. The Promise of TechBio w/ Alaa Halawa & Ayman AlAbdallah @ Mubadala Ventures

September 15, 2021 07:52 - 43 minutes - 32.3 MB

Alaa Halawa & Ayman AlAbdallah are two integral members of the Mubadala Ventures team & lead the firm’s efforts in TechBio. Alaa Halawa is the Co-Head of Mubadala Capital Ventures SF, where he focuses on investing in venture and early growth-stage companies at the intersection of life sciences and technology. Among other themes within life sciences investing, Alaa has concentrated on the following: how technology is enhancing the pharmaceutical industry, from drug discovery through clinica...

26. Genetic & Cellular Engineering: David Schaffer - Professor @ Berkeley

August 20, 2021 19:23 - 43 minutes - 27.3 MB

David Schaffer is a Professor of Chemical & Biomolecular Engineering, Bioengineering, & Neuroscience @ University of California Berkeley, he also serves as the Director of QB3 - Berkeley.  At Berkeley, Schaffer applies engineering principles to enhance Stem Cell & Gene Therapy approaches for Neuro-Regeneration. This work includes mechanistic investigation of stem cell control, as well as molecular evolution & engineering of viral gene delivery vehicles.  He has Co-founded six companies inc...

25. Advancing Women's Health & Diversity In Biotech: Jennifer Friel Goldstein - Managing Partner @ SVB Capital

August 20, 2021 10:31 - 43 minutes - 27.1 MB

Jennifer Friel Goldstein is the Managing Partner for Life Science & Healthcare Practice @ SVB Capital and is a founding member of Venture Forward, a nonprofit that provides resources and education toward developing a diverse, equitable and inclusive venture capital (VC) ecosystem. She is also an advisory board member of Springboard Enterprises and the Women’s Health Innovation Coalition. Jennifer has more than 20 years of experience in the VC and startup market segments, including leading ...

24. Tech Eats Bio: Vijay Pande - General Partner @ Andreessen Horowitz (a16z) Bio Fund

August 17, 2021 19:09 - 43 minutes - 38 MB

Vijay Pande is a General Partner @ Andreessen Horowitz (a16z), where he focuses on investments in Biopharma & Healthcare. As the founding investor of a16z’s Bio Fund, Vijay leads the firm’s investments at the cross section of biology and computer science, including applications in computation, machine learning, and artificial intelligence in healthcare; digital therapeutics; diagnostics; and other novel transformative scientific advances applied to industry that take bio beyond healthcare....

23. Translational Bioengineering: Angelika Fretzen - COO & Tech Translation Director @ Wyss Institute

August 04, 2021 17:44 - 43 minutes - 29.1 MB

Angelika Fretzen is the Wyss Institute’s Technology Translation Director and COO, applying product and entrepreneurial business development experience to the Institute’s mission of taking impactful technologies in healthcare and sustainability from the lab into their real world application. She leads a team at the Wyss that is dedicated to building a unique model of innovation, technology development and commercialization, in a community of strong collaborators within an extensive ecosystem ...

22. Scaling TechBio: Shaan Gandhi - Director @ Northpond Ventures

July 27, 2021 07:42 - 43 minutes - 131 MB

Shaan Gandhi is a Director @ Northpond Ventures and leads the firm’s work in biotechnologies. Shaan is a board director at Aro Biotherapeutics; CAMP4 Therapeutics; Candel Therapeutics; DiCE Molecules; StrideBio, Inc.; Triumvira Immunologics, Inc.; and Vigil Neuroscience. Previously, Shaan was a Principal at the Longwood Fund, where he created and invested in life sciences companies, including Pyxis Oncology, a cancer immunotherapy company focused on novel modulators of the tumor microenviron...

21. Biotech Startup Revolution: Jared Friedman - Managing Director @ Y Combinator

July 27, 2021 07:03 - 43 minutes - 24.3 MB

Jared Friedman is a Managing Director @ Y Combinator, where he works with YC's bio companies. Y Combinator has funded over 400 healthcare and bio companies across all sectors. YC currently funds more healthcare/bio companies per year than any other investor in the world. Thank you for listening! BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting earl...

20. VC Firm Building: Cain McClary - Founder @ KdT Ventures

July 20, 2021 16:49 - 43 minutes - 30 MB

Cain McClary is Founder & Managing Partner @ KdT Ventures, a venture capital firm focused on supporting startups re-architecting the world at a molecular level. Cain is a Physician/Scientist and Venture Capitalist, leveraging technical scientific and medical knowledge/experience as well as an extensive network of scientists, clinicians, entrepreneurs, and funders to guide and invest in young companies at the intersection of computation and science. His experiences on both sides of the table...

19. Rise of TechBio VC: Shahram Seyedin-Noor - General Partner @ Civilization Ventures

June 28, 2021 02:30 - 43 minutes - 60.1 MB

Shahram is Founder and General Partner of Civilization Ventures, a venture capital firm focused on supporting cutting edge innovations in health tech and biology. Prior to founding Civilization Ventures, Shahram was a life sciences entrepreneur and angel investor for more than a decade. Shahram was the founding CEO and later Executive Chairman of Rgenix, a biotech company with multiple first-in-class therapeutics for cancer now in Phase 1b clinical trials. Prior to Rgenix, he was founding C...

19. Rise of an Operator Investor: Shahram Seyedin-Noor - General Partner @ Civilization Ventures

June 28, 2021 02:30 - 43 minutes - 60.1 MB

Shahram Seyedin-Noor is Founder and General Partner of Civilization Ventures, a venture capital firm focused on supporting cutting edge innovations in health tech and biology. Prior to founding Civilization Ventures, Shahram was a life sciences entrepreneur and angel investor for more than a decade. Shahram was the founding CEO and later Executive Chairman of Rgenix, a biotech company with multiple first-in-class therapeutics for cancer now in Phase 1b clinical trials. Prior to Rgenix, he w...

18. Catalyzing SynBio: Ron Weiss - Professor @ MIT

June 16, 2021 06:59 - 58 minutes - 119 MB

Ron Weiss is one of the pioneers of synthetic biology. He has been engaged in synthetic biology research since 1996 when he was a graduate student at MIT and where he helped set up a wet-lab in the Electrical Engineering and Computer Science Department. After completion of his PhD, Weiss joined the faculty at Princeton University, and recently returned to MIT to take on a tenured faculty position in the Department of Biological Engineering and the Department of Electrical Engineering and Com...

17. Academic Entrepreneurship: George Church - Professor @ Harvard / Core Faculty @ Wyss Institute

June 15, 2021 06:23 - 135 MB

George Church leads Synthetic Biology at the Wyss Institute, where he oversees the directed evolution of molecules, polymers, and whole genomes to create new tools with applications in regenerative medicine and bio-production of chemicals. Among his recent work at the Wyss is development of a technology for synthesizing whole genes, and engineering whole genomes, far faster, more accurate, and less costly than current methods. George is widely recognized for his innovative contributions to g...

17. Academic Entrepreneurship: George Church - Professor @ Harvard

June 15, 2021 06:23 - 135 MB

George Church leads Synthetic Biology at the Wyss Institute, where he oversees the directed evolution of molecules, polymers, and whole genomes to create new tools with applications in regenerative medicine and bio-production of chemicals. Among his recent work at the Wyss is development of a technology for synthesizing whole genes, and engineering whole genomes, far faster, more accurate, and less costly than current methods. George is widely recognized for his innovative contributions to g...

Twitter Mentions

@alixventures 56 Episodes
@bios_community 56 Episodes
@jimmyjqian 3 Episodes
@obbadkamal 3 Episodes
@robertpearlmd 2 Episodes
@swiftscalebio 1 Episode
@vasudevbailey 1 Episode